Patients with organ-confined prostate cancer may have a new treatment option using high doses of focused stereotactic body radiotherapy (SBRT) instead of traditional lengthy radiotherapy courses or surgery, according to new data presented at the American Society for Radiation Oncology annual meeting. Read More.
Multivitamin use had no effect on the incidence of prostate cancer, which was the most common cancer diagnosed in the study participants. When researchers looked at the effect of vitamin use on all other cancers, they found a 12 percent reduction in occurrence. Read More.
Men with metastatic castration-resistant prostate cancer (CRPC) lived significantly longer when treated with a bone-targeted, alpha-emitting agent, a randomized trial showed. Read More.